Anup D. Patel, MD: Long-Term Use of CBD in Lennox-Gastaut Syndrome Pubblicato il 1 dic 2018 New long-term data from an open-label extension trial of cannabidiol (CBD) in patients with Lennox-Gastuat Syndrome (LGS) showed that the therapy remains well-tolerated past a total of 4 years of use.